Manager × security

Canaan Partners XI LLC TYRA holdings history

Who else holds this security? →

TYRA BIOSCIENCES INC · CUSIP 90240B106 · CIK 1850694

This is the oldest quarter open without an account, so changes against the quarter before it are withheld. Sign in to see them.
Citable facts

As of 2026-06-30, Canaan Partners XI LLC reported 750.00K TYRA (shares), valued at $23.95M, or 18.82% of its reported non-derivative portfolio. Filed 2026-07-20.

Verify history & sources →
Portfolio weight and quantity history
Reported portfolio weight
18.82%
Shares
750.00K
750,000
Reported value
$23.95M
USD

Shares unchanged; reported value decreased 16.61%, and weight changed -18.94 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.

Left: % · Right: Shares · Independently scaled axes

Exact data and methodology

Axes scale independently; a crossing does not mean equal values. Weight uses each quarter's total reported non-derivative value. Same CUSIP; missing quarters are gaps, not zero. Revised history may include later disclosures.

QuarterWeightQuantitySource
Q2 202618.82%750,000SEC filing ↗Filed Jul 20, 2026
Q1 202637.76%750,000SEC filing ↗Filed Apr 24, 2026
Q4 202564.85%3,374,329SEC filing ↗Filed Feb 13, 2026
Q3 202549.07%3,608,109SEC filing ↗Filed Oct 23, 2025
Q2 202520.10%3,608,109SEC filing ↗Filed Jul 17, 2025
Q1 202558.09%4,144,590SEC filing ↗Filed Apr 9, 2025
Q4 202475.17%4,179,857SEC filing ↗Filed Jan 21, 2025
Q3 202487.81%4,409,991SEC filing ↗Filed Oct 16, 2024
Q2 202485.38%4,409,991SEC filing ↗Filed Jul 9, 2024
Q1 202479.77%4,409,991SEC filing ↗Filed Apr 5, 2024
Q4 202376.34%4,409,991SEC filing ↗Filed Feb 1, 2024

History & evidence by quarter

QuarterWeightQuantityValueChange explainedSource
Q4 202376.34%4,409,991$61.08MThe prior quarter is outside the free window. Sign in for the comparison.SEC filing ↗
Filed Feb 1, 2024
Q1 202479.77%4,409,991$72.32MShares unchanged; reported value increased 18.41%, and weight changed +3.43 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Apr 5, 2024
Q2 202485.38%4,409,991$70.52MShares unchanged; reported value decreased 2.50%, and weight changed +5.61 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jul 9, 2024
Q3 202487.81%4,409,991$103.68MShares unchanged; reported value increased 47.03%, and weight changed +2.43 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Oct 16, 2024
Q4 202475.17%4,179,857$58.10MShares decreased 5.22%; reported value decreased 43.96%, and weight changed -12.64 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jan 21, 2025
Q1 202558.09%4,144,590$38.54MShares decreased 0.84%; reported value decreased 33.66%, and weight changed -17.08 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Apr 9, 2025
Q2 202520.10%3,608,109$34.53MShares decreased 12.94%; reported value decreased 10.42%, and weight changed -37.99 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jul 17, 2025
Q3 202549.07%3,608,109$50.48MShares unchanged; reported value increased 46.19%, and weight changed +28.97 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Oct 23, 2025
Q4 202564.85%3,374,329$88.71MShares decreased 6.48%; reported value increased 75.74%, and weight changed +15.78 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Feb 13, 2026
Q1 202637.76%750,000$28.73MShares decreased 77.77%; reported value decreased 67.62%, and weight changed -27.09 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Apr 24, 2026
Q2 202618.82%750,000$23.95MShares unchanged; reported value decreased 16.61%, and weight changed -18.94 pp. Weight depends on both the security valuation and total portfolio value, not trade proceeds.SEC filing ↗
Filed Jul 20, 2026
Canaan Partners XI LLC · TYRA BIOSCIENCES INC

Take these holdings further.

This page includes 11 of 11 reported holdings. Sign in to look up the full history beyond 3 years, use advanced screening & filtering, download CSV, and get the complete set through the Akkru API.

  • Download CSV
  • Earlier quarters
  • Advanced screening & filtering
  • API & AI access
Already have an account?

+ New accounts get free API credits to explore data beyond ownership filings.

For AI agents & developers

The initial HTML of this page carries its exact data as script#research-data (JSON): values, units, scope, preview limits and SEC sources. Read it directly, no script or API key needed; script#research-access says what needs an account.

Without an account: the last 3 years, with the row caps stated on the page. A free account opens all history on file on these pages and the CSV of what a page shows. Rows beyond the caps and bulk retrieval go through the authenticated API / MCP.

MCP  https://api.akkrudata.ai/mcp

get_institutional_portfolio
{"cik":"1850694","quarter":"2026Q2","cusip":"90240B106"}

get_institutional_manager_history
{"cik":"1850694","page_size":100}

Connect to MCP with OAuth and follow the returned pagination. Credits and usage limits depend on the account.

MCP endpoint
https://api.akkrudata.ai/mcp
API / MCP documentation
/documents
llms.txt
/llms.txt
Sources, coverage & how to read this data

Figures are as reported to the SEC and merged with later amendments where Akkru could match them. Preview limits apply to what is listed, not to the totals, which come from the complete reported data. Nothing is zero-filled: a missing quarter or month is shown as missing.

13F reports quarter-end long positions in securities traded on US exchanges, filed by managers holding at least $100 million of such securities; it is not the manager's full portfolio, not assets under management, and value changes are not returns. Weights use the reported total value as denominator. Option rows show notional value, not premium or net exposure. Amendments are merged into the quarter when Akkru could match them.